Invention Grant
- Patent Title: Polypeptides of Leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
- Patent Title (中): 利什曼原虫多肽和编码相同的多核苷酸及其疫苗，治疗和诊断应用
-
Application No.: US11887956Application Date: 2006-04-07
-
Publication No.: US07888492B2Publication Date: 2011-02-15
- Inventor: Mehdi Chenik , Sami Lakhal , Hechmi Louzir , Koussay Dellagi
- Applicant: Mehdi Chenik , Sami Lakhal , Hechmi Louzir , Koussay Dellagi
- Applicant Address: FR Paris TN Tunis
- Assignee: Institut Pasteur,Institut Pasteur De Tunis
- Current Assignee: Institut Pasteur,Institut Pasteur De Tunis
- Current Assignee Address: FR Paris TN Tunis
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: CA2503932 20050408; CA2540736 20060405
- International Application: PCT/EP2006/003978 WO 20060407
- International Announcement: WO2006/108720 WO 20061019
- Main IPC: C07H21/04
- IPC: C07H21/04
Abstract:
The present invention relates to new proteins of Leishmania major and to therapeutical and diagnostic applications thereof. More particularly, the present invention relates to excreted/secreted polypeptides and polynucleotides encoding same, compositions comprising the same, and methods of diagnosis, vaccination and treatment of Leishmaniasis.
Public/Granted literature
Information query
